[1]
“PHARMACOEPIDEMIOLOGY OF HEPATOPROTECTORS USED IN THE HOSPITALS OF THE KHOREZM REGION”, ReFocus, vol. 3, no. 7, pp. 89–95, Aug. 2024, doi: 10.66073/researchfocus.v3i7.826.